GLUE
Monte Rosa Therapeutics, Inc. Common Stock
$17.81
-3.08%
-0.57
Notify me if price changes either direction
Buy GLUE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.4B
Enterprise value
815.8M
Trailing PE
56
Forward PE
-12.972535
PEG Ratio
1.0952769553459
Enterprise to EBITDA
48.445
Enterprise to revenue
4.494
Price to book MRQ
4.503644
Price to sales TTM
7.526084
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
181.5M
EBITDA
16.8M
Diluted EPS TTM
0.32
Total Cash (MRQ)
391.3M
Current ratio (MRQ)
6.54
Operating Cash Flow (TTM)
149.1M
GLUE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
February 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
